glucagon receptor - Robuta Search

https://pubmed.ncbi.nlm.nih.gov/39011638/ Glucagon Receptor Antagonist for Heart Failure With Preserved Ejection Fraction These findings identify glucagon receptor signaling in cardiomyocytes as a critical determinant of HFpEF progression and provide proof-of-concept support for... glucagon receptor heart failure antagonist preserved ejection https://journals.ed.ac.uk/gtopdb-cite/article/view/11709/14078 View of Glucagon receptor family in GtoPdb v.2025.3 glucagon receptor view family https://pmc.ncbi.nlm.nih.gov/articles/PMC8961394/ Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary... Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been widely recommended for glucose control and cardiovascular risk reduction in patients with type... https://pmc.ncbi.nlm.nih.gov/articles/PMC4216654/ Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists - PMC Patients with type 2 diabetes have a several-fold increased risk of developing cardiovascular disease when compared with nondiabetic controls. Myocardial... glp receptor cardiovascular effects glucagon like https://dukespace.lib.duke.edu/items/c6a1a1dc-d2f5-4d97-bd29-bd63f3104031 Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog... https://pubmed.ncbi.nlm.nih.gov/39002641/ Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized,... https://pubmed.ncbi.nlm.nih.gov/31020810/ Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy GLP-1R agonists ameliorate muscle wasting by suppressing MSTN and muscle atrophic factors and enhancing myogenic factors through GLP-1R-mediated signalling... https://pubmed.ncbi.nlm.nih.gov/39578156/ Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance... GLP-1RAs were notably associated with reports of impaired gastric emptying in the FAERS. Age, weight, and sex were significantly associated with impaired... https://www.repository.cam.ac.uk/items/8eb76cfb-bcd8-41b0-9532-6ab61c616396 Risk of Fracture With Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists,... Aim: This study aims to investigate the association between the use of dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like peptide-1 receptor agonists... https://pmc.ncbi.nlm.nih.gov/articles/PMC8796881/ Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among... Are there inequities in glucagon-like peptide-1 receptor agonist (GLP-1 RA) use based on race, ethnicity, sex, and socioeconomic status among patients with... https://scholars.okstate.edu/en/publications/tirzepatide-a-novel-glucose-dependent-insulinotropic-polypeptideg/fingerprints/ Tirzepatide: A Novel Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide 1 Receptor... a novel https://pubmed.ncbi.nlm.nih.gov/38848064/ Bariatric Metabolic Surgery vs Glucagon-Like Peptide-1 Receptor Agonists and Mortality In this cohort study, BMS was associated with greater reduced mortality compared with first-generation GLP-1RAs among individuals with a diabetes duration of... bariatric metabolic surgery https://researchconnect.buffalo.edu/en/publications/glucagon-like-peptide-1-receptor-activation-in-the-ventral-tegmen/ Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine... https://www.news-medical.net/news/20130718/TSRI-scientists-study-3-D-structure-of-glucagon-receptor-for-treatment-of-diabetes.aspx TSRI scientists study 3-D structure of glucagon receptor for treatment of diabetes Jun 24, 2019 - The study is reported on July 17, 2013, in an advance online edition of the journal Nature, alongside a British laboratory's structural study of another member... https://pmc.ncbi.nlm.nih.gov/articles/PMC11206448/ Potential Role of Phytochemicals as Glucagon-like Peptide 1 Receptor (GLP-1R) Agonists in the... Currently, there is no known cure for diabetes. Different pharmaceutical therapies have been approved for the management of type 2 diabetes mellitus (T2DM),... https://pmc.ncbi.nlm.nih.gov/articles/PMC7566932/ Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance - PMC https://research.birmingham.ac.uk/en/publications/effect-of-combination-treatment-with-glucagon-like-peptide-1-rece/ Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose... https://pmc.ncbi.nlm.nih.gov/articles/PMC9918402/ Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the... Weight regain after bariatric surgery occurs in up to a third of patients and reduces treatment-associated health benefits. The efficacy of glucagon-like... https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/1852/ "Modulation of glucagon receptor expression and response in transfected" by T. Ikegami, A.M. Cypess... By T. Ikegami, A.M. Cypess, and B. Bouscarel, Published on 01/01/01 https://portal.fis.tum.de/en/publications/glucagon-cell-hyperplasia-and-neoplasia-with-and-without-glucagon/ Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations - Technical... glucagon cell hyperplasia neoplasia without https://scholars.duke.edu/publication/1638380 Scholars@Duke publication: The impact of glucagon-like peptide-1 receptor agonists in the patients... https://yorkspace.library.yorku.ca/items/cdd8ef87-1f2f-43b4-b4d3-aaa9af99d728/full Effects of Somatostatin Receptor 2 Inhibition on Glucagon Counterregulation and C-Peptide Levels in... The counterregulatory hormone glucagon prevents hypoglycemia; however, recurrent hypoglycemia attenuates glucagon counterregulation to subsequent hypoglycemia.... https://ctgate.cci.fsu.edu/generalizability-of-glucagon-like-peptide-1-receptor-agonist-cardiovascular-outcome-trials-enrollment-criteria-to-the-us-type-2-diabetes-population/ Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials... Title : Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population... generalizability glucagon like peptide https://mydss.mo.gov/media/pdf/glucagon-peptide-1-glp-1-receptor-agonists-indicated-obesity-pdl-edit Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Indicated for Obesity PDL Edit | mydss.mo.gov https://pubmed.ncbi.nlm.nih.gov/41547366/ Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic,... GLP-1 receptor agonists were initially developed to treat type 2 diabetes and have had a transformative effect on its therapy, and are highly effective for... next generation glucagon like receptor agonists https://spiral.imperial.ac.uk/entities/publication/fb93d06f-7ce5-46f0-9486-0ccfd585265c Effects of glucagon-like peptide-1 receptor agonists on histopathological and secondary biomarkers... https://pmc.ncbi.nlm.nih.gov/articles/PMC10563602/ Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned? - PMC Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have changed considerably the management of type 2 diabetes (T2D). However, recently published data from... https://portal.fis.tum.de/en/publications/glucagon-like-peptide-1-versus-somatostatin-receptor-targeting-re/ Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of... https://pure.psu.edu/en/publications/sleep-is-increased-by-liraglutide-a-glucagon-like-peptide-1-recep/ Sleep is increased by liraglutide, a glucagon-like peptide-1 receptor agonist, in rats - Penn State https://pmc.ncbi.nlm.nih.gov/articles/PMC5401818/ Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2... The prevalence of type 2 diabetes (T2D) is increasing worldwide. Patients with T2D suffer from various diabetes-related complications. Since there are many... https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.678055/full Frontiers | The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in... The glucagon-like peptide 1 receptor (GLP-1R) is a class B G protein-coupled receptor (GPCR) which mediates the effects of GLP-1, an incretin hormone secrete... https://pmc.ncbi.nlm.nih.gov/articles/PMC10775775/ Medicare formulary restrictions for glucagon-like peptide 1 receptor agonists and sodium glucose... Glucagon-like peptide 1 receptor agonists (GLP1-RAs) and sodium glucose cotransporter 2 inhibitors (SGLT2is) have proven benefits in patients with type 2... https://experts.umn.edu/en/publications/predictors-of-weight-loss-response-with-glucagon-like-peptide-1-r-2/ Predictors of weight-loss response with glucagon-like peptide-1 receptor agonist treatment among... https://collections.nlm.nih.gov/?f%5Bdrep2.subjectAggregate%5D%5B%5D=Glucagon-Like+Peptide-1+Receptor+Agonists&per_page=20&sort=drep3.titleSortForm+asc Subjects: Glucagon-Like Peptide-1 Receptor Agonists - Digital Collections - National Library of... https://ctgate.cci.fsu.edu/generalizability-of-glucagon-like-peptide-1-receptor-agonist-cardiovascular-outcome-trials-to-the-overall-type-2-diabetes-population-in-the-united-states/ Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the... Title : Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United... https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1566498/full Frontiers | Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a... BackgroundGlucagon-like peptide-1 receptor agonist (GLP-1RA) pharmaceutical interventions have advanced medical treatment for obesity, yet little is known ab... https://pmc.ncbi.nlm.nih.gov/articles/PMC7911747/ Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and... To assess the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for treatment of nonalcoholic fatty liver disease (NAFLD) or steatohepatitis... https://research.vu.nl/en/publications/structure-of-the-full-length-glucagon-class-b-g-protein-coupled-r/ Structure of the full-length glucagon class B G-protein-coupled receptor - Vrije Universiteit... https://pmc.ncbi.nlm.nih.gov/articles/PMC10423473/ Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis... Obesity is a risk factor for knee osteoarthritis (KOA) development and progression. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are indicated for type... https://events.diabetes.org/p/s/results-of-first-phase-3-study-of-retatrutide-a-gip-glp-1-and-glucagon-receptor-agonist-in-patients-with-obesity-triumph-1-5581 Results of First Phase 3 Study of Retatrutide, a GIP, GLP-1, and Glucagon Receptor Agonist in... https://pubmed.ncbi.nlm.nih.gov/35647711/ A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor Peptide agonists of the glucagon-like peptide-1 receptor (GLP-1R) have revolutionized diabetes therapy, but their use has been limited because they require... https://experts.arizona.edu/en/projects/investigating-the-role-of-hepatic-glucagon-receptor-signaling-in-/ Investigating the Role of Hepatic Glucagon Receptor Signaling in Healthspan and Aging - University... https://pmc.ncbi.nlm.nih.gov/articles/PMC11177512/ Efficacy and safety of glucagon-like peptide-1 receptor agonists on prediabetes: a systematic... Prediabetes is a condition preceding the development of diabetes and is associated with an increased risk of a number of complications. The primary mode of... efficacy and safety https://pmc.ncbi.nlm.nih.gov/articles/PMC10892952/ Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data... Background: A potential risk of suicide associated with liraglutide or semaglutide treatments has recently emerged. Therefore, we decided to investigate the... https://pubmed.ncbi.nlm.nih.gov/39911047/ Quantitative Comparison of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Adults: A... The objective of this study is to quantitatively compare the weight loss effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in adult patients with... https://pubmed.ncbi.nlm.nih.gov/39030327/ Multiple sclerosis patients taking glucagon-like peptide-1 receptor (GLP-1) agonists: a... Obesity is a risk factor for developing and worsening multiple sclerosis (MS) and is often comorbid with MS, exacerbating disability. We retrospectively... multiple sclerosis https://pubmed.ncbi.nlm.nih.gov/39829337/ Safety and effectiveness in an uncontrolled setting of glucagon-like-peptide-1 receptor agonists in... GLP-1RA significantly improved BMI, HbA1c and triglycerides in a large majority of patients with FPLD. Larger and prospective controlled studies are warranted... https://pubmed.ncbi.nlm.nih.gov/39774820/ Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and the... In patients with type 2 diabetes in the U.K., GLP-1RAs were not associated with a lower risk of cirrhosis compared with DPP-4 inhibitors in patients with type... https://pubmed.ncbi.nlm.nih.gov/40471562/ Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration In this cohort study, the use of GLP-1 RAs among patients with diabetes was associated with a 2-fold higher risk of incident nAMD development than among... https://events.diabetes.org/p/s/what-does-glucagon-receptor-agonism-add-to-the-effects-of-gip-and-glp-1-receptor-agonism-5584 What Does Glucagon Receptor Agonism Add to the Effects of GIP and GLP-1 Receptor Agonism? -... https://www.wikidata.org/wiki/Q28316345 Effects of iodination of tyrosyl residues on the binding and action of glucagon at its receptor -... scientific article (publication date: 5 October 1976) https://pubchem.ncbi.nlm.nih.gov/bioassay/1345918 AID 1345918 - Rat GLP-1 receptor (Glucagon receptor family) - PubChem BioAssay record AID 1345918 submitted by IUPHAR/BPS Guide to PHARMACOLOGY: Rat GLP-1 receptor (Glucagon receptor family). aid rat glp receptor glucagon https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1153648/full Frontiers | Glucagon-like peptide-1 receptor-agonists treatment for cardio-metabolic parameters in... Aims: We performed this meta-analysis to evaluate the efficacy and safety of glucagon-like peptide-1 receptor-agonists (GLP-1RA) treatment on cardio-metaboli... https://pubmed.ncbi.nlm.nih.gov/34213657/?dopt=Abstract Breast Cancer, Diabetes Mellitus and Glucagon-Like Peptide-1 Receptor Toward Exploring Their... These findings all demonstrated the possible association between GLP-1R status and biological features of BC, especially of invasive BC in DM patients.